key: cord-0883328-shl8s7lt authors: Casey, Kyla; Iteen, Alexander; Nicolini, Reese; Auten, Jonathan title: COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection date: 2020-04-08 journal: Am J Emerg Med DOI: 10.1016/j.ajem.2020.04.011 sha: 7ff1d388067d117a5705ba4d1259d0851f9361c4 doc_id: 883328 cord_uid: shl8s7lt Recent retrospective studies from Wuhan, China suggest Novel Coronavirus Disease 2019 (COVID-19) may be associated with a hypercoagulable state and increased risk for venous thromboembolism. The overlap in the signs and symptoms of COVID-19 associated Acute Respiratory Distress Syndrome (ARDS) and COVID-19 with concurrent pulmonary embolism creates a diagnostic challenge for emergency medicine physicians in patients already at risk for renal impairment. However, identifying features atypical for COVID-19 alone may play a role in the judicious use of Computed Tomography Angiography among these patients. Hemoptysis is seen in roughly 13% of pulmonary embolism cases and infrequently reported among COVID-19 infections. Additionally, the presence of right heart strain on electrocardiography (EKG) is a well described clinical presentations of pulmonary embolism not reported commonly with COVID-19 infections. J o u r n a l P r e -p r o o f The full spectrum of COVID-19 disease is still emerging, but several research studies have highlighted that patients suffering from COVID-19 tend to have high d-dimers, fibrinogen and fibrin degradation products [3, 7] . Additional research has suggested that these patients may have a mortality benefit from anticoagulation [7] . During the Severe Acute Respiratory Syndrome (SARS) outbreak in 2002-2003 and H1N1 influenza pandemic in 2009 case reports described concurrent PE with viral lung infections [8, 9] . Data from murine models suggests that SARS-CoV may interact with urokinase to produce a hypercoagulable state observed in SARS related acute lung injury [10] . An association between COVID-19 and PE creates a diagnostic challenge for emergency medicine clinicians given the overlap in symptoms between the two clinical entities. Elevated D-Dimer levels (>1.0 mg/dl) have been identified as a potential predictor of increased mortality, but are not specific to the diagnosis of VTE [11, 12] . Reliance on D-dimer as a screening tool should be discouraged in this patient population and may lead to over utilization of Computed Tomography Angiography (CTA) in a patient population already at risk for acute kidney injury [1, 12] However, hemoptysis has been described as an infrequent COVID clinical symptom (0-5%) by retrospective analysis from Wuhan, China and may be useful in setting pretest probability [11, 13] . Clinical Characteristics of Coronavirus Disease 2019 in China Clinical and immunologic features in severe and moderate Coronavirus Disease Prominent Changes in Blood Coagulation of Patients with SARS-CoV-2 Infection. Clinical Chemistry and Laboratory Medicine (CCLM) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study COVID-19 Complicated by Acute Pulmonary Embolism. Radiology: Cardiothoracic Imaging Acute pulmonary embolism and COVID-19 pneumonia: a random association? Anticoagulant Treatment Is Associated with Decreased Mortality in Severe Coronavirus Disease 2019 Patients with Coagulopathy Pulmonary Artery Thrombosis in a Patient with Severe Acute Respiratory Syndrome Thromboembolic events in patients with severe pandemic influenza A/H1N1 Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical features of patients infected with 2019 novel coronavirus in Wuhan